Tridiuum Board of Directors

Mark Redlus, Tridiuum CEO

With two decades of senior executive leadership experience, Redlus had served as chief executive or a member of the executive team in companies ranging from small institutionally venture-backed start-ups to midsized enterprises across a variety of industries, including software, technology, healthcare, environmental, cleantech and energy before being elevated to Tridiuum CEO in October 2017. He is an expert in product development and strategy, and has had multiple successful exits.

John Martinson, chairman, Martinson Ventures

Martinson has been a venture capitalist for four decades, participating in more than 200 equity financings and serving as a director of 55 companies. In 1986 he founded Edison Partners, which has: raised eight partnerships with more than $1 billion in assets under management; invested in more than 210 growth businesses; and exited more than 155 companies. Martinson is former chairman of the National Venture Capital Association, where he served as a director for eight years, and also is co-founder and former chairman of the New Jersey Technology Council, as well as former chairman of the Greater Philadelphia Venture Group, which merged into the Philadelphia Alliance for Capital and Technologies.

Mark Groner, principal, Sopris Capital

Groner has been involved in principal investing and investment banking since 2004. He began his career in the Investment Banking Division of Citigroup Global Markets, where he focused on mergers and acquisitions, and financing transactions in the industrial, consumer, and automotive industries. He then joined Linden Capital Partners, a Chicago-based private equity firm focused exclusively on leveraged buyouts in the healthcare industry. Groner received a B.S. degree in finance from Indiana University’s Kelley School of Business and an M.B.A. from the University of Chicago’s Booth School of Business.

Albert (Al) Wiegman, head of Fresenius Medical Care Ventures at Fresenius Medical Care North America

With some two decades of experience in venture capital, Wiegman has generated a successful track record across the technology and healthcare sectors, directly participating in 30 early-stage venture investments in software, healthcare IT, medical devices and healthcare services. He has strategic and operational expertise, and is a hands-on board member adept at actively assisting portfolio companies in facilitating growth, financing and exit opportunities.

Jennifer (Jenn) Hartt, director of investments, health & digital health, Ben Franklin Technology Partners Southeastern Pennsylvania (board observer)

Hartt directs all of Ben Franklin’s life-sciences-related investments in companies with technologies ranging from clinical healthcare IT, medical devices and diagnostics to therapeutics. She has closed 140 investments totaling more than $33M in 70+ companies for Ben Franklin since early 2006.

Integrating behavioral health into total health

© 2019 Tridiuum. All Rights Reserved. Tridiuum and Behavioral Health Index are trademarks of Tridiuum, Inc. Any other names of actual companies, organizations, entities, products or services may be the trademarks of their respective owners.

Funding News

Tridiuum Secures $9.5 Million in Series B Financing
Read Release